Long-Term Effectiveness of Evolocumab in Reducing the Risk for Major Adverse Cardiovascular Events: Comparing FOURIER OLE Data to External Control Using a Principled Approach (AHA 2026) - Sep 5, 2026 - Abstract #6839; Pres time: Nov 8, 2026; 04:15 PM - 04:25 PM; Location: N231; In-Person; No abstract available
Adverse events • Cardiovascular
|
|
M. Brookhart; Nafeesa Dhalwani; Francesco Giorgianni; Robert Giugliano; KyungAh Im; Hengyi Ke; Shia Kent; Timothy Lash; Lyrica Liu; David Neasham; Michelle O'Donoghue; Gabriel Paiva da Silva Lima; Marc Sabatine; Swati Sakhuja; Emileigh Walsh
|